SGLT2 inhibitor ertugliflozin decreases elevated intracellular sodium, and improves energetics and contractile function in diabetic cardiomyopathy

BACKGROUND: Elevated myocardial intracellular sodium ([Na(+)](i)) was shown to decrease mitochondrial calcium ([Ca(2+)](MITO)) via mitochondrial sodium/calcium exchanger (NCXMITO), resulting in decreased mitochondrial ATP synthesis. The sodium-glucose co-transporter 2 inhibitor (SGLT2i) ertugliflozi...

Descripción completa

Detalles Bibliográficos
Autores principales: Croteau, Dominique, Baka, Tomas, Young, Sara, He, Huamei, Chambers, Jordan M., Qin, Fuzhong, Panagia, Marcello, Pimentel, David R., Balschi, James A., Colucci, Wilson S., Luptak, Ivan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992115/
https://www.ncbi.nlm.nih.gov/pubmed/36731341
http://dx.doi.org/10.1016/j.biopha.2023.114310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992115/
https://www.ncbi.nlm.nih.gov/pubmed/36731341
http://dx.doi.org/10.1016/j.biopha.2023.114310

Ejemplares similares